Gene · 4880
Papers1,757
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,757
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cardiomyocyte-derived C-type natriuretic peptide diminishes myocardial ischaemic injury by promoting revascularisation and limiting fibrotic burden. | Pharmacol Res | 2024 | 39374886 | PubTator, text mining | PubMed |
| C-type natriuretic peptide (CNP): The cardiovascular system and beyond. | Pharmacol Ther | 2024 | 39154787 | PubTator, text mining | PubMed |
| Auto/Paracrine C-Type Natriuretic Peptide/Cyclic GMP Signaling Prevents Endothelial Dysfunction. | Int J Mol Sci | 2024 | 39063044 | PubTator, text mining | PubMed |
| Exploring the Therapeutic Potential of C-Type Natriuretic Peptide for Preeclampsia. | Hypertension | 2024 | 39016006 | PubTator, text mining | PubMed |
| Discovery of small molecule guanylyl cyclase B receptor positive allosteric modulators. | PNAS Nexus | 2024 | 38894878 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived apoptotic vesicles ameliorate impaired ovarian folliculogenesis in polycystic ovary syndrome and ovarian aging by targeting WNT signaling. | Theranostics | 2024 | 38855175 | PubTator, text mining | PubMed |
| C-type natriuretic peptide/cGMP/FoxO3 signaling attenuates hyperproliferation of pericytes from patients with pulmonary arterial hypertension. | Commun Biol | 2024 | 38844781 | PubTator, text mining | PubMed |
| Molecular therapy and nucleic acid adeno-associated virus-based gene therapy delivering combinations of two growth-associated genes to MPS IVA mice. | Mol Ther Nucleic Acids | 2024 | 38831899 | PubTator, text mining | PubMed |
| Neprilysin Inhibition Promotes Skeletal Growth via the CNP/NPR-B Pathway. | Endocrinology | 2024 | 38752331 | PubTator, text mining | PubMed |
| Sacubitril/Valsartan inhibits M1 type macrophages polarization in acute myocarditis by targeting C-type natriuretic peptide. | Biomed Pharmacother | 2024 | 38581923 | PubTator, text mining | PubMed |
| HAPLN1 knockdown inhibits heart failure development via activating the PKA signaling pathway. | BMC Cardiovasc Disord | 2024 | 38580957 | PubTator, text mining | PubMed |
| Proteome-Wide Changes in Blood Biomarkers During Hemodialysis. | Kidney Int Rep | 2024 | 38312796 | PubTator, text mining | PubMed |
| Review of published 467 achondroplasia patients: clinical and mutational spectrum. | Orphanet J Rare Dis | 2024 | 38281003 | PubTator, text mining | PubMed |
| Hypertensive Heart Disease: A Narrative Review Series-Part 3: Vasculature, Biomarkers and the Matrix of Hypertensive Heart Disease. | J Clin Med | 2024 | 38256639 | PubTator, text mining | PubMed |
| Changes in vascular function and correlation with cardiotoxicity in women with newly diagnosed breast cancer undergoing HER2-directed therapy with and without anthracycline/cyclophosphamide. | Eur Heart J Open | 2024 | 38239934 | PubTator, text mining | PubMed |
| Advancements in drug-loaded hydrogel systems for bone defect repair. | Regen Ther | 2024 | 38230308 | PubTator, text mining | PubMed |
| EDNRB inhibits the growth and migration of prostate cancer cells by activating the cGMP-PKG pathway. | Open Med (Wars) | 2024 | 38205153 | PubTator, text mining | PubMed |
| 2',3' cyclic nucleotide 3' phosphodiesterase 1 functional isoform antagonizes HIV-1 particle assembly. | Life Sci Alliance | 2024 | 38167610 | PubTator, text mining | PubMed |
| Deciphering expression and variants in cardiovascular disease genes among heart failure population for precision medicine. | ESC Heart Fail | 2024 | 38131165 | PubTator, text mining | PubMed |
| Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial. | Lancet Child Adolesc Health | 2024 | 37984383 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4880/papers?page=5